Novartis India Limited submitted a regulatory disclosure regarding the audio recording of an Analyst/Institutional Investor Call. The call was held on Friday, September 11, 2026, at 4:00 P.M. (IST) through both virtual and physical modes.
This disclosure follows previous intimations dated September 08, 2026 (regarding the call schedule) and September 11, 2026 (regarding the investor presentation submission).
The audio recording of the call has been uploaded on the Company's website and is available at: https://nilpharma.co.in/investoranalyst-calls/
The Company specifically confirmed that no unpublished price sensitive information was shared or discussed during the call.
The document was digitally signed by Chandni Bhupendra Maru (Membership Number: A60291), who serves as Company Secretary and Compliance Officer of Novartis India Limited, on September 12, 2026 at 14:49:23 IST.